[Experimental 2,4-dichlorophenoxyacetate myopathy. I. Electrophysiological and histochemical results].
D000200:Action Potentials; D000818:Animals; D004576:Electromyography; D005260:Female; D005964:Glucosyltransferases; D006003:Glycogen; D006008:Glycogen Storage Disease; D006016:Glycolates; D006651:Histocytochemistry; D006846:Hydrocarbons, Halogenated; D009119:Muscle Contraction / Q000187:drug effects; D009129:Muscle Tonus / Q000187:drug effects; D009132:Muscles / Q000201:enzymology; D009135:Muscular Diseases / Q000139:chemically induced* / Q000473:pathology; D009210:Myofibrils / Q000032:analysis; D006005:Phosphorylases / Q000378:metabolism; D051381:Rats; D011919:Rats, Inbred Strains
D006016:Glycolates; D006846:Hydrocarbons, Halogenated; D006003:Glycogen; D005964:Glucosyltransferases; D006005:Phosphorylases
Zur experimentellen 2,4-Dichlorphenoxyazetat-Myopathie. I. Elektrophysiologische, morphologische und histochemische Befunde.